RSM’s Tammy Hill discusses opportunities for PE investment in behavioral healthcare, both in the long term and short term.

Five years into the historic legislation, the asset class is focusing on new subsectors within healthcare, say experts from GTCR and Healthcare Royalty Partners.

Moss Adams partner DeVon Wiens details what areas of the healthcare sector are attracting and repelling private equity investments.

Baird Capital’s Mike Liang discusses the appeal of investing in a company that makes products aimed at preventing hospital-acquired infections.

Investing in real estate in the medical space remains somewhat unusual for private equity firms, which have tended to focus on acquisitions of healthcare companies.

Shore Capital’s focus on a small niche subsector belies a larger plan for its latest acquisition.

An executive summary of the Privcap webinar: “The Healthcare Private Equity Opportunity”

Healthcare-focused firm Sterling Partners continues to keep its eye on this specific part of an important subsector

How the Canadian PE firm invests in the country’s segmented healthcare system

Learn how private equity firms are partnering with healthcare innovators to build value in a rapidly changing market.

GTCR is betting on a healthcare revolution in the coming years, assembling a management team to source deals in the sector, says managing director Dean Mihas.

As one of the largest and most successful European private equity investors in the healthcare sector, Cinven has a good handle on what trends and topics that investors in the space are looking at.

GTCR’s Dean Mihas tells Privcap about his firm’s exit of medical-devices business Devicor and how “The Leadership Strategy” was used to build the portfolio company.

In this subscriber-only special report, Privcap talks to private equity leaders who invest in the healthcare sector about what investment opportunities exist, including in emerging markets, and how private capital and innovation are combining to build value in a changing market.

Cleveland Clinic’s Gary Fingerhut explains how the clinic commercializes healthcare innovations.

Two partners from Baird Capital discuss where they’re investing in healthcare, where there are risks, and what’s in the future for the sector.

Baird Capital’s Mike Liang and Michael Bernstein discuss whether there’s appetite among limited partners for investing in healthcare.

Outgoing CVCA president Peter van der Velden discusses his accomplishments with the association, and the outlook for investing in the healthcare innovation sector.